Skip to content
1887
  1. Home
  2. A-Z Publications
  3. Johnson Matthey Technology Review
  4. Volume 61, Issue 1
  5. Article
Volume 61, Issue 1
  • ISSN: 2056-5135
file format pdf download PDF

Abstract

It was some 50 years ago that Barnett Rosenberg and coworkers published their studies on unusual patterns of bacterial growth that led to the identification of platinum compounds as highly effective agents against some cancers, particularly those of genitourinary origin. This sparked a renewed interest around the world in the potential of metal compounds as small molecule therapeutic agents. Some of that history, particularly related to the platinum group metals (pgm) platinum and ruthenium, is described in this overview.

© Johnson Matthey
Loading

Article metrics loading...

/content/journals/10.1595/205651317X693624
2017-01-01
2024-11-05
Loading full text...

Full text loading...

/deliver/fulltext/jmtr/61/1/JMTR-61-1-Barnard.html?itemId=/content/journals/10.1595/205651317X693624&mimeType=html&fmt=ahah

References

  1. J. Reedijk, Platinum Metals Rev., 2008, 52, (1), 2 LINK http://www.technology.matthey.com/article/52/1/2-11/ [Google Scholar]
  2. B. Rosenberg, L. Van Camp, T. Krigas, Nature, 1965, 205, (4972), 698 LINK http://dx.doi.org/10.1038/205698a0 [Google Scholar]
  3. B. Rosenberg, L. VanCamp, J. E. Trosko, V. H. Mansour, Nature, 1969, 222, (5191), 385 LINK http://dx.doi.org/10.1038/222385a0 [Google Scholar]
  4. E. R. Jamieson, S. J. Lippard, Chem. Rev., 1999, 99, (9), 2467 LINK http://dx.doi.org/10.1021/cr980421n [Google Scholar]
  5. U.-M. Ohndorf, M. A. Rould, Q. He, C. O. Pabo, S. J. Lippard, Nature, 1999, 399, (6737), 708 LINK http://dx.doi.org/10.1038/21460 [Google Scholar]
  6. E. Cvitkovic, J. Spaulding, V. Bethune, J. Martin, W. F. Whitmore, Cancer, 1977, 39, (4), 1357 LINK http://dx.doi.org/10.1002/1097-0142(197704)39:4<1357::AID-CNCR2820390402>3.0.CO;2-C [Google Scholar]
  7. M. J. Cleare, J. D. Hoeschele, Bioinorg. Chem., 1973, 2, (3), 187 LINK http://dx.doi.org/10.1016/S0006-3061(00)80249-5 [Google Scholar]
  8. M. J. Cleare, Coord. Chem. Rev., 1974, 12, (4), 349 LINK http://dx.doi.org/10.1016/S0010-8545(00)82029-9 [Google Scholar]
  9. T. A. Connors, M. J. Cleare, K. R. Harrap, Cancer Treat. Rep., 1979, 63, (9–10), 1499 LINK https://www.ncbi.nlm.nih.gov/pubmed/498149 [Google Scholar]
  10. K. R. Harrap, Cancer Treat. Rev., 1985, 12, (A), 21 LINK http://dx.doi.org/10.1016/0305-7372(85)90015-5 [Google Scholar]
  11. C. F. J. Barnard, M. J. Cleare, P. C. Hydes, Chem. Br., 1986, 22, 1001 [Google Scholar]
  12. N. J. Wheate, S. Walker, G. E. Craig, R. Oun, Dalton Trans., 2010, 39, (35), 8113 LINK http://dx.doi.org/10.1039/c0dt00292e [Google Scholar]
  13. J. B. Vermorken, W. W. ten Bokkel Huinink, J. G. McVie, W. J. F. van der Vijgh, H. M. Pinedo, I. H. Krakoff, ‘Clinical Experience with 1,1-Diaminomethylcyclohexane (Sulphato) Platinum (II) (TNO-6)’, Platinum Coordination Complexes in Cancer Chemotherapy, Vermont Regional Cancer Center and the Norris Cotton Cancer Center, USA, 22nd–24th June, 1983, “Proceedings of the Fourth International Symposium on Platinum Coordination Complexes in Cancer Chemotherapy”, eds. M. P. Hacker, E. B. Douple, Martinus Nijhoff Publishing, Boston, USA, 1984, p. 330 [Google Scholar]
  14. M. C. Christian, Semin. Oncol., 1992, 19, (6), 720 [Google Scholar]
  15. G. Mathé, Y. Kidani, M. Noji, R. Maral, C. Bourut, E. Chenu, Cancer Lett., 1985, 27, (2) 135 LINK http://dx.doi.org/10.1016/0304-3835(85)90102-8 [Google Scholar]
  16. G. Mathé, Y. Kidani, K. Triana, S. Brienza, P. Ribaud, E. Goldschmidt, E. Ecstein, R. Despax, M. Musset, J. L. Misset, Biomed. Pharmacother., 1986, 40, (10), 372 LINK https://www.ncbi.nlm.nih.gov/pubmed/3580505 [Google Scholar]
  17. A. N. Boughattas, F. Lévi, C. Fournier, G. Lemaigre, A. Roulon, B. Hecquet, G. Mathé, A. Reinberg, Cancer Res., 1989, 49, (12), 3362 LINK https://www.ncbi.nlm.nih.gov/pubmed/2720689 [Google Scholar]
  18. F. Lévi, J.-L. Misset, S. Brienza, R. Adam, G. Metzger, M. Itzakhi, J. P. Caussanel, F. Kunstlinger, S. Lecouturier, A. Descorps-Declère, C. Jasmin, H. Bismuth, A. Reinberg, Cancer, 1992, 69, (4), 893 LINK https://doi.org/10.1002/1097-0142(19920215)69:4%3C893::AID-CNCR2820690410%3E3.0.CO;2-X [Google Scholar]
  19. C. M. Giandomenico, M. J. Abrams, B. A. Murrer, J. F. Vollano, M. I. Rheinheimer, S. B. Wyer, G. E. Bossard, J. D. Higgins, Inorg. Chem., 1995, 34, (5), 1015 LINK http://dx.doi.org/10.1021/ic00109a004 [Google Scholar]
  20. M. J. McKeage, P. Mistry, J. Ward, F. E. Boxall, S. Loh, C. O’Neill, P. Ellis, L. R. Kelland, S. E. Morgan, B. A. Murrer, P. Santabarbara, K. R. Harrap, I. R. Judson, Cancer Chemother. Pharmacol., 1995, 36, (6), 451 LINK http://dx.doi.org/10.1007/BF00685793 [Google Scholar]
  21. A. M. Thayer, Chem. Eng. News, 2010, 88, (26), 24 LINK http://dx.doi.org/10.1021/cen-v088n026.p024 [Google Scholar]
  22. L. R. Kelland, C. F. J. Barnard, Drugs Fut., 1998, 23, (10), 1062 LINK http://dx.doi.org/10.1358/dof.1998.023.10.473361 [Google Scholar]
  23. L. R. Kelland, S. Y. Sharp, C. F. O’Neill, F. I. Raynaud, P. J. Beale, I. R. Judson, J. Inorg. Biochem., 1999, 77, (1–2), 111 LINK http://dx.doi.org/10.1016/S0162-0134(99)00141-5 [Google Scholar]
  24. L. R. Kelland, C. F. J. Barnard, I. G. Evans, B. A. Murrer, B. R. C. Theobald, S. B. Wyer, P. M. Goddard, M. Jones, M. Valenti, A. Bryant, P. M. Rogers, K. R. Harrap, J. Med. Chem., 1995, 38, (16), 3016 LINK http://dx.doi.org/10.1021/jm00016a004 [Google Scholar]
  25. L. R. Kelland, C. F. J. Barnard, K. J. Mellish, M. Jones, P. M. Goddard, M. Valenti, A. Bryant, B. A. Murrer, K. R. Harrap, Cancer Res., 1994, 54, (21), 5618 LINK https://www.ncbi.nlm.nih.gov/pubmed/7923207 [Google Scholar]
  26. K. J. Mellish, C. F. J. Barnard, B. A. Murrer, L. R. Kelland, Int. J. Cancer, 1995, 62, (6), 717 LINK http://dx.doi.org/10.1002/ijc.2910620612 [Google Scholar]
  27. P. M. Goddard, R. M. Orr, M. R. Valenti, C. F. J. Barnard, B. A. Murrer, L. R. Kelland, K. R. Harrap, Anticancer Res., 1996, 16, (1), 33 LINK https://www.ncbi.nlm.nih.gov/pubmed/8615631 [Google Scholar]
  28. N. Farrell, L. R. Kelland, J. D. Roberts, M. Van Beusichem, Cancer Res., 1992, 52, (18), 5065 LINK https://www.ncbi.nlm.nih.gov/pubmed/1516063 [Google Scholar]
  29. N. Farrell, Cancer Invest., 1993, 11, 578 [Google Scholar]
  30. K. S. Lovejoy, S. J. Lippard, Dalton Trans., 2009, (48), 10651 LINK http://dx.doi.org/10.1039/b913896j [Google Scholar]
  31. D. I. Jodrell, T. R. J. Evans, W. Steward, D. Cameron, J. Prendiville, C. Aschele, C. Noberasco, M. Lind, J. Carmichael, N. Dobbs, G. Camboni, B. Gatti, F. De Braud, Eur. J. Cancer, 2004, 40, (12), 1872 LINK http://dx.doi.org/10.1016/j.ejca.2004.04.032 [Google Scholar]
  32. T. A. Hensing, N. H. Hanna, H. H. Gillenwater, M. G. Camboni, C. Allievi, M. A. Socinski, Anticancer Drugs, 2006, 17, (6), 697 LINK http://dx.doi.org/10.1097/01.cad.0000215054.62942.7f [Google Scholar]
  33. M. J. Clarke, Met. Ions Biol. Syst., 1980, 11, 231 [Google Scholar]
  34. G. Sava, E. Alessio, A. Bergamo, G. Mestroni, P. J. Sadler, ‘Sulfoxide Ruthenium Complexes: Non Toxic Tools for the Selective Treatment of Solid Tumour Metastases’, in “Metallopharmaceuticals I”, eds. M. J. Clarke, Topics in Biological Inorganic Chemistry, Springer-Verlag, Heidelberg, Germany, 1999, p. 143 [Google Scholar]
  35. S. Leijen, S. A. Burgers, P. Baas, D. Pluim, M. Tibben, E. van Werkhoven, E. Alessio, G. Sava, J. H. Beijnen, J. H. M. Schellens, Invest. New Drugs, 2015, 33, (1), 201 LINK http://dx.doi.org/10.1007/s10637-014-0179-1 [Google Scholar]
  36. R. Trondl, P. Heffeter, C. R. Kowol, M. A. Jakupec, W. Berger, B. K. Keppler, Chem. Sci., 2014, 5, (8), 2925 LINK http://dx.doi.org/10.1039/C3SC53243G [Google Scholar]
  37. A. Bergamo, G. Sava, Dalton Trans., 2011, 40, (31), 7817 LINK http://dx.doi.org/10.1039/c0dt01816c [Google Scholar]
  38. Y. K. Yan, M. Melchart, A. Habtemariam, P. J. Sadler, Chem. Commun., 2005, (38), 4764 LINK http://dx.doi.org/10.1039/b508531b [Google Scholar]
  39. A. L. Noffke, A. Habtemariam, A. M. Pizarro, P. J. Sadler, Chem. Commun., 2012, 48, (43), 5219 LINK http://dx.doi.org/10.1039/c2cc30678f [Google Scholar]
  40. W. H. Ang, E. Daldini, C. Scolaro, R. Scopelliti, L. Juillerat-Jeannerat, P. J. Dyson, Inorg. Chem., 2006, 45, (22), 9006 LINK http://dx.doi.org/10.1021/ic061008y [Google Scholar]
  41. B. Serli, E. Zangrando, T. Gianferrara, C. Scolaro, P. J. Dyson, A. Bergamo, E. Alessio, Eur. J. Inorg. Chem., 2005, (17), 3423 LINK http://dx.doi.org/10.1002/ejic.200500210 [Google Scholar]
  42. I. Bratsos, S. Jedner, A. Bergamo, G. Sava, T. Gianferrara, E. Zangrando, E. Alessio, J. Inorg. Biochem., 2008, 102, (5–6), 1120 LINK http://dx.doi.org/10.1016/j.jinorgbio.2008.01.005 [Google Scholar]
  43. G. Süss-Fink, Dalton Trans., 2010, 39, (7), 1673 LINK http://dx.doi.org/10.1039/B916860P [Google Scholar]
  44. C. M. Clavel, E. Paunescu, P. Nowak-Sliwinska, A. W. Griffioen, R. Scopelliti, P. J. Dyson, J. Med. Chem., 2014, 57, 3546 LINK http://dx.doi.org/10.1021/jm5002748 [Google Scholar]
  45. X. Meng, M. L. Leyva, M. Jenny, I. Gross, S. Benosman, B. Fricker, S. Harlepp, P. Hébraud, A. Boos, P. Wlosik, P. Bischoff, C. Sirlin, M. Pfeffer, J.-P. Loeffler, C. Gaiddon, Cancer Res., 2009, 69, (13), 5458 LINK http://dx.doi.org/10.1158/0008-5472.CAN-08-4408 [Google Scholar]
/content/journals/10.1595/205651317X693624
Loading
Platinum Group Metal Compounds in Cancer Chemotherapy
Johnson Matthey Technology Review 61, 52 (2017); https://doi.org/10.1595/205651317X693624
/content/journals/10.1595/205651317X693624
/content/journals/10.1595/205651317X693624
Loading

Data & Media loading...

  • Article Type: Research Article

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test